#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Lupus nephritis Li-Fraumeni syndrome Gastrointestinal disorder Frostbite Arrhythmia Haematological malignancy Richter's syndrome Thalassaemia alpha Small cell lung cancer limited stage Bronchopulmonary aspergillosis Anti-neutrophil cytoplasmic antibody positive vasculitis Liposarcoma Hidradenitis Metastases to peritoneum Thalassaemia More trials…

    Learn about Rare Diseases

    Optic glioma Advanced systemic mastocytosis Indolent systemic mastocytosis – Life with Disease Waldenstrom’s macroglobulinaemia – Trials in Disease Mantle cell lymphoma – Life with Disease Pleomorphic leiomyosarcoma – Treatment Niemann-Pick disease – Basic Information Antithrombin III deficiency – Treatment Retinitis pigmentosa – Trials in Disease Glomerulonephritis membranoproliferative – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Botulinum Toxin Type A Gadobenate Dimeglumine Dolutegravir Eye103 Meglumine Gadoterate Sar-443579 Toripalimab Xylitol Gtaexs617 Imipenem Monohydrate Nicotine Resinate Casimersen Folic Acid Belumosudil Mesilate Itacitinib Efzofitimod Dsimc Vincristine Sulfate Balstilimab Indocyanine Green More therapies…

    Learn about Your Condition

    Retinopathy of prematurity Testicular leiomyosarcoma Burning mouth syndrome Implantation complication Sickle cell disease Asthmatic crisis Langerhans' cell histiocytosis Embolism venous Connective tissue disorder Methylmalonic acidaemia Malignant lymphoid neoplasm Neck pain Malignant melanoma of eyelid Neoplasm Eye disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Acromegaly

  • Study of Debio 4126, a new octreotide formulation, compared to placebo in patients with acromegaly who were previously treated with somatostatin analogs

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acromegaly
    Investigated Drugs:
    • Lanreotide
    • Octreotide
    Austria Belgium Bulgaria Denmark Estonia France +10

  • Study on the Effects of Pegvisomant and Somatropin on Liver Fat Metabolism in Patients with Acromegaly and Healthy Individuals

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acromegaly
    Investigated Drugs:
    • PEGVISOMANT
    • Somatropin
    Austria

  • Study of ALXN2420 with somatostatin analogs for adults with acromegaly to evaluate effectiveness in lowering IGF-1 levels

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Acromegaly
    Investigated Drugs:
    • ALXN2420
    • Octreotide Acetate
    Denmark Hungary Italy Lithuania The Netherlands Poland +1

  • Study on the Long-Term Safety and Efficacy of Paltusotine for Patients with Acromegaly

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Acromegaly
    Investigated Drugs:
    • Paltusotine
    Germany Greece Hungary

  • Study on the Safety and Effectiveness of Paltusotine for Patients with Acromegaly

    Not recruiting

    3 1
    Investigated Drugs:
    • Paltusotine
    Belgium Bulgaria France Hungary Italy Poland

  • Study on the Effects of Paltusotine for Patients with Untreated Acromegaly

    Not recruiting

    3 1
    Investigated Drugs:
    • Paltusotine
    Bulgaria France Germany Greece Hungary Italy +1
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!